Patent · US Active

Tetracycline compounds

US9573895B2 · kind B2 · utility

6Cited by

29References

10Claims

0Family size

Assignee

Tetraphase Pharmaceuticals, Inc. · US

Inventors

Xiao-Yi Xiao · San Diego, US
Roger B. Clark · Middletown, US
Diana Katharine Hunt · Cambridge, US
Cuixiang Sun · Watertown, US
Magnus P. Ronn · Melrose, US
Wu-Yan Zhang · Lexington, US
Minsheng He · Andover, US

Key dates

Filing date	Aug 30, 2013
Grant date	Feb 21, 2017
Priority date	—
Expiry date	Aug 30, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.